相似文献
1
Pharmacologic Approach to Heart Failure in Children.
Curr Cardiol Rev. 2016;12(2):117-20. doi: 10.2174/1573403X12666151119165438.
2
Pharmacologic Approach to Heart Failure.
Curr Cardiol Rev. 2015 Nov 19.
3
Pharmacologic therapy of chronic heart failure.
Am J Cardiovasc Drugs. 2007;7(4):235-48. doi: 10.2165/00129784-200707040-00002.
4
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.
Eur J Heart Fail. 2016 Jun;18(6):716-26. doi: 10.1002/ejhf.531. Epub 2016 Apr 29.
5
Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Chronic Heart Failure.
Pediatr Crit Care Med. 2016 Mar;17(3 Suppl 1):S20-34. doi: 10.1097/PCC.0000000000000624.
6
Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
JACC Heart Fail. 2016 May;4(5):333-44. doi: 10.1016/j.jchf.2015.11.011. Epub 2016 Feb 10.
7
[Acute and chronic cardiac decompensation: is vasodilator therapy useful?].
Minerva Med. 1982 Jan 14;73(1-2):25-32.
8
Overview of current noninodilator therapies for acute heart failure syndromes.
Am J Cardiol. 2005 Sep 19;96(6A):41G-6G. doi: 10.1016/j.amjcard.2005.07.020.
9
Kidney failure: cardiorenal and venorenal.
Adv Chronic Kidney Dis. 2014 Nov;21(6):453-5. doi: 10.1053/j.ackd.2014.09.002. Epub 2014 Oct 24.
10
[Drug treatment for chronic heart failure with reduced ejection fraction].
Ther Umsch. 2011 Feb;68(2):71-9. doi: 10.1024/0040-5930/a000123.
引用本文的文献
1
A Review of the Mechanism of Action of Drugs Used in Congestive Heart Failure in Pediatrics.
Cureus. 2023 Jan 16;15(1):e33811. doi: 10.7759/cureus.33811. eCollection 2023 Jan.
本文引用的文献
1
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan.
Int J Cardiol. 2012 Aug 23;159(2):82-7. doi: 10.1016/j.ijcard.2011.07.022. Epub 2011 Jul 23.
2
Diuretic strategies in patients with acute decompensated heart failure.
N Engl J Med. 2011 Mar 3;364(9):797-805. doi: 10.1056/NEJMoa1005419.
3
Combination of loop diuretics with thiazide-type diuretics in heart failure.
J Am Coll Cardiol. 2010 Nov 2;56(19):1527-34. doi: 10.1016/j.jacc.2010.06.034.
4
Cardiopulmonary interaction.
Pediatr Crit Care Med. 2009 May;10(3):313-22. doi: 10.1097/PCC.0b013e31819887f0.
5
Carvedilol for children and adolescents with heart failure: a randomized controlled trial.
JAMA. 2007 Sep 12;298(10):1171-9. doi: 10.1001/jama.298.10.1171.
6
Levosimendan, a new inotropic and vasodilator agent.
Anesthesiology. 2006 Mar;104(3):556-69. doi: 10.1097/00000542-200603000-00024.
7
Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Heart. 2005 Aug;91(8):1080-5. doi: 10.1136/hrt.2004.035618.
8
Peripheral vascular effects of noradrenaline, isopropylnoradrenaline and dopamine.
Br Med Bull. 1963 May;19:132-6. doi: 10.1093/oxfordjournals.bmb.a070031.
9
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Lancet. 2003 Sep 6;362(9386):772-6. doi: 10.1016/S0140-6736(03)14284-5.
10
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
Lancet. 2003 Jul 5;362(9377):7-13. doi: 10.1016/S0140-6736(03)13800-7.
Zotero 插件